2009 Chapter 961

961.14(2)(bm) (bm) Alphameprodine;

961.14(2)(c) (c) Alphamethadol;

961.14(2)(cd) (cd) Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);

961.14(2)(cg) (cg) Alpha-methylthiofentanyl (N-{1-[1-methyl-2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);

961.14(2)(cm) (cm) Benzethidine;

961.14(2)(d) (d) Betacetylmethadol;

961.14(2)(dg) (dg) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);

961.14(2)(dm) (dm) Betameprodine;

961.14(2)(e) (e) Betamethadol;

961.14(2)(em) (em) Betaprodine;

961.14(2)(er) (er) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy- 2-phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);

961.14(2)(f) (f) Clonitazene;

961.14(2)(fm) (fm) Dextromoramide;

961.14(2)(gm) (gm) Diampromide;

961.14(2)(h) (h) Diethylthiambutene;

961.14(2)(hg) (hg) Difenoxin;

961.14(2)(hm) (hm) Dimenoxadol;

961.14(2)(j) (j) Dimepheptanol;

961.14(2)(jm) (jm) Dimethylthiambutene;

961.14(2)(k) (k) Dioxaphetyl butyrate;

961.14(2)(km) (km) Dipipanone;

961.14(2)(m) (m) Ethylmethylthiambutene;

961.14(2)(mm) (mm) Etonitazene;

961.14(2)(n) (n) Etoxeridine;

961.14(2)(nm) (nm) Furethidine;

961.14(2)(p) (p) Hydroxypethidine;

961.14(2)(pm) (pm) Ketobemidone;

961.14(2)(q) (q) Levomoramide;

961.14(2)(qm) (qm) Levophenacylmorphan;

961.14(2)(qs) (qs) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4- piperidinyl]-N-phenylpropanamide);

961.14(2)(r) (r) Morpheridine;

961.14(2)(rg) (rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);

961.14(2)(rj) (rj) 3-methylthiofentanyl (N-{3-methyl-1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);

961.14(2)(rm) (rm) Noracymethadol;

961.14(2)(s) (s) Norlevorphanol;

961.14(2)(sm) (sm) Normethadone;

961.14(2)(t) (t) Norpipanone;

961.14(2)(tg) (tg) Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);

961.14(2)(tm) (tm) Phenadoxone;

961.14(2)(u) (u) Phenampromide;

961.14(2)(um) (um) Phenomorphan;

961.14(2)(v) (v) Phenoperidine;

961.14(2)(vg) (vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);

961.14(2)(vm) (vm) Piritramide;

961.14(2)(w) (w) Proheptazine;

961.14(2)(wm) (wm) Properidine;

961.14(2)(wn) (wn) Propiram;

961.14(2)(x) (x) Racemoramide;

961.14(2)(xm) (xm) Thiofentanyl (N-{1-[2-(2-thienyl)ethyl]-4-piperidinyl}-N-phenylpropanamide);

961.14(2)(xr) (xr) Tilidine;

961.14(2)(y) (y) Trimeperidine.

961.14(3) (3) Substances derived from opium. Any material, compound, mixture or preparation which contains any quantity of any of the following substances derived from opium, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation:

961.14(3)(a) (a) Acetorphine;

961.14(3)(b) (b) Acetyldihydrocodeine;

961.14(3)(c) (c) Benzylmorphine;

961.14(3)(d) (d) Codeine methylbromide;

961.14(3)(e) (e) Codeine-N-oxide;

961.14(3)(f) (f) Cyprenorphine;

961.14(3)(g) (g) Desomorphine;

961.14(3)(h) (h) Dihydromorphine;

961.14(3)(hm) (hm) Drotebanol;

961.14(3)(j) (j) Etorphine, except its hydrochloride salts;

961.14(3)(k) (k) Heroin;

961.14(3)(m) (m) Hydromorphinol;

961.14(3)(n) (n) Methyldesorphine;

961.14(3)(p) (p) Methyldihydromorphine;

961.14(3)(q) (q) Morphine methylbromide;

961.14(3)(r) (r) Morphine methylsulfonate;

961.14(3)(s) (s) Morphine-N-oxide;

961.14(3)(t) (t) Myrophine;

961.14(3)(u) (u) Nicocodeine;

961.14(3)(v) (v) Nicomorphine;

961.14(3)(w) (w) Normorphine;

961.14(3)(x) (x) Pholcodine;

961.14(3)(y) (y) Thebacon.

961.14(4) (4) Hallucinogenic substances. Any material, compound, mixture or preparation which contains any quantity of any of the following hallucinogenic substances, including any of their salts, isomers and salts of isomers that are theoretically possible within the specific chemical designation, in any form including a substance, salt, isomer or salt of an isomer contained in a plant, obtained from a plant or chemically synthesized:

961.14(4)(a) (a) 3,4-methylenedioxyamphetamine, commonly known as "MDA";

961.14(4)(ag) (ag) 3,4-methylenedioxyethylamphetamine, commonly known as "MDE";

961.14(4)(am) (am) 3,4-methylenedioxymethamphetamine, commonly known as "MDMA";

961.14(4)(ar) (ar) N-hydroxy-3,4-methylenedioxyamphetamine;

961.14(4)(b) (b) 5-methoxy-3,4-methylenedioxyamphetamine;

961.14(4)(bm) (bm) 4-ethyl-2,5-dimethoxyamphetamine, commonly known as "DOET";

961.14(4)(c) (c) 3,4,5-trimethoxyamphetamine;

961.14(4)(cm) (cm) Alpha-ethyltryptamine;

961.14(4)(d) (d) Bufotenine;

961.14(4)(e) (e) Diethyltryptamine;

961.14(4)(f) (f) Dimethyltryptamine;

961.14(4)(g) (g) 4-methyl-2,5-dimethoxyamphetamine, commonly known as "STP";

961.14(4)(h) (h) Ibogaine;